Details of the Drug Reposition

General Information of This Drug (ID: DMGSX7D)

Drug Name
Shan 6   DMGSX7D

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pertussis DIS60FPT 1C12 Phase 3 [1]
------------------------------------------------------------------------------------
6 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Tetanus DISVMFVD 1C13 Phase 2 [2]
Diphtheria DISZWM55 1C17 Phase 2 [2]
Poliomyelitis DISANFJN 1C81 Phase 2 [2]
Poliovirus infection DISEU9EO 1C8Y Phase 2 [2]
Hepatitis B virus infection DISLQ2XY 1E51.0 Phase 2 [2]
Haemophilus influenza DISIY76O 1G40 Phase 2 [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Indications(s)

References

1 ClinicalTrials.gov (NCT04429295) Study of DTwP-HepB-Hib-IPV (SHAN6) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)